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destroy, simultaneously, up to 286,441 metric tons of
plasticizer-containing food on June 11, 2011, in 11 counties
and cities, under the supervision of the Bureau of Health
Promotion and the Bureau of Environmental Protection. A
total of 426 food producers and 965 food products were
involved in the food safety scandal, which was initially
investigated by the Taiwanese authorities on May 23, and
represented the first reported event of a plasticizer being
intentionally added to food.
The culprit plasticizer, di-(2-ethylhexyl)phthalate (DEHP),
is an industrial chemical used mainly for making the poly-
vinyl chloride soft and flexible. DEHP was incidentally found
initially in a probiotic powder and subsequently in many
other food items and neutraceutical products in Taiwan.
DEHP is a potential human carcinogen that has, therefore,
been banned from children’s toys in many countries,
including Taiwan. The Taiwanese authorities discovered
that some food-additive distributors had illegally added the
banned industrial plasticizer to a stabilizing emulsifier, as
a cheap substitute for palmitic acid. The resulting product,
a clouding agent, was then used by many famous food
manufacturers in fruit-flavored juices, jams and jellies, as
well as in neutraceutical pills/powders, sports drinks, tea
drinks, and other beverages.
DEHP is, categorized as a phthalate belonging to a family
of endocrine-disrupting chemicals, defined as exogenous
substances that interfere with the synthesis, secretion,
binding action, and metabolism of the natural endogenous
hormones regulating homeostasis, reproduction, and devel-
opmental processes in the body.1 Phthalates are not onlyE-mail address: jinyinglu@ntuh.gov.tw.
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doi:10.1016/j.jfma.2011.07.002used for industrial purposes, but also added to polyvinyl
chloride-containing plastics including children’s toys and
medical devices, and to fragrant cosmetics and a variety of
varnished household items. DEHP is the most widely used
phthalate because of its low cost. Although exposure to DEHP
can be oral, dermal, parenteral or inhalational, studies
revealed that most exposure occurred by means of dietary
routes, thought to be the result of leaching of DEHP from
plastic wrappers or plastic materials in food production
processes.2
The levels of DEHP in food rarely exceed 1.0 parts per
million (ppm).3 However, analysis of flavored sports drinks
produced in Taiwan revealed that many of them
contained DEHP at levels above 14 ppm. Based on an
example of a 14-kg 4-year-old child consuming around one
250-mL cup of the flavored sports drink each day, the daily
DEHP consumption would be more than 10 times the safety
reference value, i.e. the tolerable daily intake (TDI) of
25 mg/kg of body weight recommended by the World Health
Organization Guidelines (Table 1).4 Such levels might be
expected to have severe detrimental effects on human
health.
DEHP has estrogenic and antiandrogenic properties, and
has been shown to cause abnormalities in the male, but
not female, reproductive system in prenatally-exposed
animals.5,6 Because of the potential health concerns,
various organizations have set TDIs for DEHP with the aim of
reducing exposure levels (Table 1). Furthermore, bio-
monitoring equivalents for specific DEHP metabolites in
urine, corresponding to the TDI estimates from these
agencies, have been derived based on data for excretion
fractions of the key urinary metabolites.2 These values may
be useful for performing DEHP risk assessments.& Formosan Medical Association. All rights reserved.
Table 1 TDI of di-(2-ethylhexyl)phthalate4,10
Organization TDI (ug/kg body weight/d) Year
US-EPA 20 1991
Health Canada 44 1994
NL-RIVM 4 1997
EU-CSTEE 37 1998
WHO 25 2003
EFSA 50 2005
EFSA Z European Food Safety Authority; EU-CSTEE Z Europe
Scientific Committee for Toxicity, Ecotoxicity and the Environ-
ment; NL-RIVM Z Netherlands Rijksinstituut voor Volksgezond-
heid en Milieu; TDI Z tolerable daily intake; US-EPA Z United
States Environmental Protection Agency; WHO Z World Health
Organization.
554 J.-Y. LuEpidemiologic studies in humans revealed that the DEHP
exposure was associated with lower testosterone levels,
sperm DNA damage, and poor semen quality. Exposure to
DEHP also resulted in a shortened ano-genital distance,
which has been linked to subfertility in men, and to early
puberty, breast cancer, and endometriosis in women.7
DEHP negatively affected neurodevelopment in children,
and might be associated with the development of attention
deficit/hyperactivity disorder.8 Finally, respiratory symp-
toms, such as allergic rhinitis and bronchial asthma, have
also been attributed to DEHP exposure.7
Although DEHP is excreted in urine within 24e48 hours of
ingestion3 and does not bioaccumulate in the body, food
contamination with DEHP could still have a great impact
on the Taiwanese population.9 Further investigation of
the exposure status of DEHP and its potential adverse
health effects on the Taiwanese population is definitely
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